[go: up one dir, main page]

WO2001081623A3 - Neuronal exprimiertes protein mit apoptoseaktivität und seine verwendung - Google Patents

Neuronal exprimiertes protein mit apoptoseaktivität und seine verwendung Download PDF

Info

Publication number
WO2001081623A3
WO2001081623A3 PCT/EP2001/004311 EP0104311W WO0181623A3 WO 2001081623 A3 WO2001081623 A3 WO 2001081623A3 EP 0104311 W EP0104311 W EP 0104311W WO 0181623 A3 WO0181623 A3 WO 0181623A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
proteins
acid sequences
inventive
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/004311
Other languages
English (en)
French (fr)
Other versions
WO2001081623A2 (de
Inventor
Bernhard Goetz
Birgitta Kammandel
Rohini Kuner
Sigrid Scheek
Holger Hiemisch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sygnis Pharma AG
Original Assignee
BASF Lynx Bioscience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Lynx Bioscience AG filed Critical BASF Lynx Bioscience AG
Priority to US10/257,763 priority Critical patent/US20050147967A1/en
Priority to AU2001254810A priority patent/AU2001254810A1/en
Priority to EP01927914A priority patent/EP1282701A2/de
Publication of WO2001081623A2 publication Critical patent/WO2001081623A2/de
Anticipated expiration legal-status Critical
Publication of WO2001081623A3 publication Critical patent/WO2001081623A3/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Die vorliegende Erfindung betrifft neue spezifisch exprimierte Proteine, und Nukleinsäuresequenzen oder rekombinante Nukleinsäurekonstrukte, die für die Proteine kodieren. Die Erfindung betrifft ausserdem Wirtsorganismen oder transgene Tiere, enthaltend die Nukleinsäuresequenzen oder rekombinanten Nukleinsäurekonstrukte sowie mono- oder polyklonale Antikörper, die gegen die isolierten Proteine gerichtet sind. Weiterhin betrifft die Erfindung ein Verfahren zum Auffinden von Substanzen mit spezifischer Bindungsaffinität an die erfindungsgemäßen Proteine, ein Verfahren zum qualitativen oder quantitativen Nachweis der erfindungsgemäßen Nukleinsäuresequenzen oder der erfindungsgemäßen Proteine. Ferner betrifft die Erfindung die Verwendung der Nukleinsäuresequenzen und Proteine.
PCT/EP2001/004311 2000-04-20 2001-04-17 Neuronal exprimiertes protein mit apoptoseaktivität und seine verwendung Ceased WO2001081623A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/257,763 US20050147967A1 (en) 2000-04-20 2001-04-17 Novel neuronally expressed protein and use thereof
AU2001254810A AU2001254810A1 (en) 2000-04-20 2001-04-17 Neuronally expressed protein having apoptotic activity, and use thereof
EP01927914A EP1282701A2 (de) 2000-04-20 2001-04-17 Neuronal exprimiertes protein mit apoptoseaktivität und seine verwendung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10019901A DE10019901A1 (de) 2000-04-20 2000-04-20 Neues neuronal exprimiertes Protein und seine Verwendung
DE10019901.1 2000-04-20

Publications (2)

Publication Number Publication Date
WO2001081623A2 WO2001081623A2 (de) 2001-11-01
WO2001081623A3 true WO2001081623A3 (de) 2002-11-28

Family

ID=7639652

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/004311 Ceased WO2001081623A2 (de) 2000-04-20 2001-04-17 Neuronal exprimiertes protein mit apoptoseaktivität und seine verwendung

Country Status (5)

Country Link
US (1) US20050147967A1 (de)
EP (1) EP1282701A2 (de)
AU (1) AU2001254810A1 (de)
DE (1) DE10019901A1 (de)
WO (1) WO2001081623A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1284288A4 (de) * 2001-01-22 2005-07-13 Shinae Kondoh Menschliche ,mit der apoptose assoziierte gene und mit hilfe dieser hergestellte menschliche, mit der apoptose assoziierte proteine

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040225A1 (en) * 1998-02-09 1999-08-12 The Johns Hopkins University School Of Medicine Immediate early genes and methods of use therefor
WO2000055175A1 (en) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. 50 human secreted proteins
WO2000076530A1 (en) * 1999-06-11 2000-12-21 Human Genome Sciences, Inc. 49 human secreted proteins
WO2001023402A1 (en) * 1999-09-27 2001-04-05 Human Genome Sciences, Inc. 43 human secreted proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6033855A (en) * 1998-02-06 2000-03-07 Millennium Pharmaceuticals, Inc. Genes encoding caspase recruitment domain polypeptides

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040225A1 (en) * 1998-02-09 1999-08-12 The Johns Hopkins University School Of Medicine Immediate early genes and methods of use therefor
WO2000055175A1 (en) * 1999-03-12 2000-09-21 Human Genome Sciences, Inc. 50 human secreted proteins
WO2000076530A1 (en) * 1999-06-11 2000-12-21 Human Genome Sciences, Inc. 49 human secreted proteins
WO2001023402A1 (en) * 1999-09-27 2001-04-05 Human Genome Sciences, Inc. 43 human secreted proteins

Also Published As

Publication number Publication date
AU2001254810A1 (en) 2001-11-07
DE10019901A1 (de) 2001-10-25
US20050147967A1 (en) 2005-07-07
EP1282701A2 (de) 2003-02-12
WO2001081623A2 (de) 2001-11-01

Similar Documents

Publication Publication Date Title
DK1025227T3 (da) Humane TOLL-homologer
WO2003001863A3 (en) Novel endothelially expressed dnas and proteins, and their use
EP0930366A3 (de) Bindungsdomänen des Serrate-proteins
EP2305715A3 (de) Monoklonaler Antikörper gegen das Osteoprotegerin-bindenden Protein
EP1392359A4 (de) Spezifische bindungsproteine und ihre verwendung
EA200700917A1 (ru) Способ рефолдинга рекомбинантных антител
WO2002020569A3 (en) Mammalian genes; related reagents and methods
WO2004033631A8 (en) Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
WO2003035847A3 (en) Il-13 mutein proteins, antibodies, compositions, methods and uses
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
ATE366420T1 (de) Kit und verfahren zur bestimmung von protein esm- 1
WO2003038041A3 (en) Il-4 mutein proteins, antibodies, compositions, methods and uses
EP3300739A3 (de) An 161p2f10b-proteine bindende antikörper und zugehörige moleküle
WO1995024481A3 (en) Humanized monoclonal antibodies against human interleukin-4
Berry et al. Use of antibody fragments in immunoaffinity chromatography: comparison of Fv fragments, VH fragments and paralog peptides
WO1995014778A3 (en) Dna sequence coding for a bmp receptor
WO2001081623A3 (de) Neuronal exprimiertes protein mit apoptoseaktivität und seine verwendung
WO2002033084A3 (en) Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
WO2002022681A3 (de) Neuronal exprimiertes protein und seine verwendung
WO2001014536A3 (de) Nukleinsäuremolekül, umfassend eine für ein hämocyanin kodierende nukleinsäuresequenz und mindestens eine intronsequenz
WO2000055192A3 (de) Hämocyanin und dafür kodierende nukleinsäuresequenz
WO2001048227A8 (en) Method for production of proteins in host cells involving the use of chaperonins
WO2003063767A3 (en) Rsv proteins, antibodies, compositions, methods and uses
WO2001085989A3 (de) Hyphenspezifische faktoren aus candida albicans
WO2001061001A3 (de) Neues zentralnervöses protein, das k+-ströme moduliert

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2001927914

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001927914

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10257763

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001927914

Country of ref document: EP